WTT Launches New Tools - CIMIT MAIN

Responsive Image
The FDA has approved the first rapid hepatitis C virus test for the U.S. market that can be used in patient care settings. The test, which was validated in part by the NIH RADx Tech program with funding from CDC, can provide results in about one hour, meaning patients with a positive test can begin treatment right away. We're honored to have been a part of the journey behind this important milestone! 

Learn more about this game changer for hepatitis C diagnosis >

Programs and Offerings

News and Events

null WTT Launches New Tools

WhenToTest.org Launches New Suite of Tools to Help Individuals Manage Their COVID Risks

BOSTON, Dec. 15, 2022—WhenToTest.org has released an all-new COVID Risk Quiz, a decision-support tool that provides individuals with guidance on their chances of having or catching COVID.

Since WhenToTest.org launched the original COVID Risk Quiz in November 2021, over 300,000 users have engaged with the tool to understand their risk of having COVID and whether they should get tested.

With the latest updates, visitors will now be able to:

  • Determine their risk of catching COVID at special events, such as weddings, concerts or holiday gatherings
  • Understand their potential risk of having COVID based on their everyday activities, such as grocery shopping or indoor dining
  • Reference an extensive library of easy-to-understand articles on how to travel, socialize, and go to work or school more safely, what to do in case of COVID exposure or a positive test, and what the latest research on the virus, vaccines, and treatments means for them
  • Find quick, clear answers to a broad array of common questions about every aspect of COVID mitigation and how to navigate life more safely in a world that includes the coronavirus

CIMIT and the Massachusetts Institute of Technology Institute for Data Systems and Society (MIT IDSS) developed WhenToTest.org with support from the NIH’s RADx Tech program.

Steven C. Schachter, M.D., CIMIT's RADx Tech chief, said, “We’re all trying to figure out how risky it is to engage in normal, everyday activities in light of the evolving challenges posed by COVID. The personalized, interactive COVID Risk Quiz helps people understand their situation and gives them confidence to participate in activities they’re comfortable with.”

“For two years, WhenToTest.org has been a valuable addition to our national COVID testing response,” said Jill Heemskerk, Ph.D., deputy director of the National Institute of Biomedical Imaging and Bioengineering, part of NIH.  “This new version makes it even easier for Americans to help safeguard themselves and their families and decide when to test. This tool complements the dedicated public health response and preparedness efforts underway across the country.”

The project was funded by NIBIB through the NIH RADx Initiative via grant #U54EB015408 and contracts #75N92021P00116 and 75N92021P00129.

About WhenToTest.org: WhenToTest.org is an online platform that supports individuals in assessing their risk for having or getting COVID, and whether to seek COVID tests based on their particular risk factors. The website also helps organizations establish effective COVID mitigation strategies and testing programs. WhenToTest.org is a joint project between CIMITand the Massachusetts Institute of Technology Institute for Data Systems and Society (MIT IDSS) with support from the National Institute of Health’s RADx Tech program.

Connect with Us

Our Lasting Impact

As an early pioneer in managing translational research, CIMIT has directly supported over 1,200 innovator teams and reviewed or consulted on over 5,000 ideas since our founding in 1998.

We work collaboratively with healthtech innovators, entrepreneurs, and institutions to ultimately make a positive impact on patient care across the globe. We streamline pathways to progress through our efficient processes, established systems, and unparalleled market expertise.